Bicyclo[2.2.2]octyltriazole inhibitors of 11β-HSD1

被引：0
|
作者：
Waddell, Sherman T. [1 ]
Gu, Xin [1 ]
Santorelli, Gina [1 ]
Graham, Donald [1 ]
Balkovec, James [1 ]
机构：
[1] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
5-MEDI
引用
收藏
页数：2
相关论文
共 50 条
  • [1] WCC 7-Medication for the fast food nation: Bicyclo[2.2.2]octyltriazole inhibitors of 11 β-HSD1 for the treatment of metabolic syndrome
    Maletic, Milana
    Leeman, Aaron
    Waddell, Sherman T.
    Balkovec, James M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [2] Bicyclo[2.2.2]octyltriazole inhibitors of 11beta-HSD1 are efficacious in animal models of metabolic disease
    Waddell, Sherman T.
    Maletic, Milana
    Santorelli, Gina
    Leeman, Aaron
    Graham, Donald
    Balkovec, James M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 798 - 798
  • [3] MEDI 229-Bicyclo[2.2.2]octyltriazole inhibitors of 11beta-HSD1 are efficacious in animal models of metabolic disease
    Murray, Desmond H.
    Lange, Linda
    Matak, Andrija A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 914 - 914
  • [4] Bicyclo[2.2.2] octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1:: Pharmacological agents for the treatment of metabolic syndrome
    Maletic, Milana
    Leeman, Aaron
    Mundt, Steven S.
    Zokian, Hratch J.
    Shah, Kashmira
    Dragovic, Jasminka
    Lyons, Kathryn A.
    Koprak, Sam L.
    Koo, Gloria C.
    Cheng, Kang
    Tan, Eugene Y.
    Thieringer, Rolf
    Vosatka, Anne Hermanowski
    Springer, Martin S.
    Balkovec, James M.
    Waddell, Sherman T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [5] Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome
    Maletic, Milana
    Leeman, Aaron
    Szymonifka, Michael
    Mundt, Steven S.
    Zokian, Hratch J.
    Shah, Kashmira
    Dragovic, Jasminka
    Lyons, Kathy
    Thieringer, Rolf
    Vosatka, Anne H.
    Balkovec, James
    Waddell, Sherman T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2568 - 2572
  • [6] Recent advances in the discovery of 11β-HSD1 inhibitors
    Boyle, Craig D.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 495 - 511
  • [7] Structure Based Design of 11β-HSD1 Inhibitors
    Singh, Suresh B.
    Tice, Colin M.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (07) : 779 - 791
  • [8] Azabicyclic sulfonamides as potent 11β-HSD1 inhibitors
    Shah, Unmesh
    Boyle, Craig D.
    Chackalamannil, Samuel
    Baker, Hana
    Kowalski, Timothy
    Lee, Julie
    Terracina, Giuseppe
    Zhang, Lili
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1551 - 1554
  • [9] 11β-HSD1 Inhibitors from Walsura cochinchinensis
    Han, Mei-Ling
    Shen, Yu
    Wang, Guo-Cai
    Leng, Ying
    Zhang, Hua
    Yue, Jian-Min
    JOURNAL OF NATURAL PRODUCTS, 2013, 76 (07): : 1319 - 1327
  • [10] The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors
    Yuan, Chester
    St. Jean, David J., Jr.
    Liu, Qingyian
    Cai, Lynn
    Li, Aiwen
    Han, Nianhe
    Moniz, George
    Askew, Ben
    Hungate, Randall W.
    Johansson, Lars
    Tedenborg, Lars
    Pyring, David
    Williams, Meredith
    Hale, Clarence
    Chen, Michelle
    Cupples, Rod
    Zhang, Jiandong
    Jordan, Steven
    Bartberger, Michael D.
    Sun, Yaxiong
    Emery, Maurice
    Wang, Minghan
    Fotsch, Christopher
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6056 - 6061
12345